The WHO for recognizing the therapeutic properties of cannabinoids
The World Health Organization (WHO) has expressed their approval for medical marijuana, recognizing it as safe and having therapeutic!
The WHO has sent a letter to the Commission on Narcotic Drugs (CND), which has its meeting in March 2019. in Vienna, advocating the exclusion of marijuana from the list of narcotic drugs from list IV. At the moment, marijuana, which was considered to be unfit for human treatment, is found next to cocaine or heroin on List IV as a substance under strict regulation. The WHO, pressured by people seeking access to cannabis for therapeutic purposes, decided to rigorously study marijuana and its substances to determine its impact on human body. After more than two years and three stages of research conducted by specialists and world experts in various fields of medicine, the WHO officially advocated that cannabinoids contained in the plant have therapeutic properties and should not be on the IV list, and more importantly, patients should have access it in the fight against their illnesses.
What does this mean for Poland and European countries?
With the support of such authority as the WHO, we can with great certainty expect that the March meeting of the CND will meet the postulate of the WHO and marijuana will be removed from List IV. What does this mean for Poland? The CND is a body deriving from the United Nations (UN), which also includes Poland. The adoption of the WHO’s postulate would be a big step forward in the medical use of cannabis around the world, because no government could now refer to this international treaty as a reason to ban the medical use of cannabis. Furthermore, according to the CND, governments would now be obliged to ensure adequate availability of cannabis to alleviate the pain and suffering of patients in their countries.
Ethan Russo, a neurologist and director of research and development at the International Marijuana and Cannabinoid Institute (ICCI), says: ‘I am pleased that the World Health Organization has recognized the scientific fact that marijuana and its derivatives have proven therapeutic properties and can be the basis for safe and effective medicines . Now it is the duty of governments of the United States and other nations to remove barriers to research on cannabis and to allow free trade across national borders and international borders.’
In addition, the WHO also recommended that the CND confirm that CBD products containing not more than 0.2% THC (and therefore also CBD oils) are not subject to international control. ‘These recommendations were unavoidable and their adoption by the UN Committee on Narcotic Drugs would contribute to improving public health around the world,’ said Dr Pavel Pachta, ICCI International Regulatory Director and former Deputy Secretary of the International Council for Drug Control (INCB) . ‘We do not expect the CND to vote against these recommendations because they come from scientific experts and are based on a rigorous scientific review,’ he adds.
The full text of the WHO letter to the CND can be found here: